Fundraising Fox

AmorChem

Venture capital

Westmount · Pre-Seed–Series B · 3 people tracked

Fox Verdict
Sign up to see your fit
Stage
Pre-Seed–Series B
HQ
Westmount, CA
Instruments
Equity
Founded
2011
AUM
$34M

Team · 3 people

from the firm's website

Frequently asked questions

What stage does AmorChem invest at?
AmorChem invests at the Pre-Seed, Seed, Series A, Series B stages.
What sectors does AmorChem focus on?
AmorChem focuses on Biotech, Healthtech, Medical Devices.
Where is AmorChem located?
AmorChem is headquartered in Westmount, CA.

Similar investors

B Capital Group

B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.

Breyer Capital

Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.

DCVC (Data Collective)

DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.

Innovestor Ventures

Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.

$270K – $3.2M
Khosla Ventures

Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.

$5K – $50M

Featured in lists